Proper Escalation Strategy from Clopidogrel to Ticagrelor; Based on Korea Acute Myocardial Infarction Registry-National Institute of Health

[Speaker] Joon Ho Ahn,Korea
Joon Ho Ahn¹, Youngkeun Ahn^1*, Min Chul Kim¹, Doo Sun Sim¹, Young Joon Hong¹, Ju Han Kim¹, Myung Ho Jeong¹, Shung-Chull Chae², In Whan Seong³, Jong Sun Park⁴, Jei Keon Chae⁵, Seung Ho Hur⁶, Kwang-Soo Cha⁷, Hyo-Soo Kim⁸, Hyeon Cheol Gwon⁹, Ki Bae Seung¹⁰, Seung Woon Rha¹¹ and other Korea Acute Myocardial Infarction Registry Investigators.
¹Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea. ²Department of Cardiology, Kyungpook National University Hospital, Daegu, Korea. ³Deparment of Cardiology, Chungnam National University Hospital, Daejeon, Korea. ⁴Department of Cardiology, Yeungnam University Hospital, Daegu, Korea. ⁵Department of Cardiology, Chonbuk National University Hospital, Jeonju, Korea^{. 6}Department of Cardiology, Keimyung University Dongsan Medical Center, Daegu, Korea. ⁷Department of Cardiology, Pusan National University Hospital, Busan, Korea. ⁸Department of Cardiology, Seoul National University Hospital, Seoul, Korea. ⁹Department of Cardiology, Samsung Medical Center, Seoul, Korea. ¹⁰Department of Cardiology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea. ¹¹Department of Cardiology, Korean University Guro Hospital, Seoul, Korea.

Statin De-escalation in Stable Acute Myocardial Infarction Patients in Korea; Based on Korea Acute Myocardial Infarction Registry-National Institute of Health

[Speaker] Joon Ho Ahn,Korea
Joon Ho Ahn¹, Youngkeun Ahn^1*, Min Chul Kim¹, Doo Sun Sim¹, Young Joon Hong¹, Ju Han Kim¹, Myung Ho Jeong¹, Shung-Chull Chae², In Whan Seong³, Jong Sun Park⁴, Jei Keon Chae⁵, Seung Ho Hur⁶, Kwang-Soo Cha⁷, Hyo-Soo Kim⁸, Hyeon Cheol Gwon⁹, Ki Bae Seung¹⁰, Seung Woon Rha¹¹ and other Korea Acute Myocardial Infarction Registry Investigators.
¹Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea. ²Department of Cardiology, Kyungpook National University Hospital, Daegu, Korea. ³Deparment of Cardiology, Chungnam National University Hospital, Daejeon, Korea. ⁴Department of Cardiology, Yeungnam University Hospital, Daegu, Korea. ⁵Department of Cardiology, Chonbuk National University Hospital, Jeonju, Korea^{. 6}Department of Cardiology, Keimyung University Dongsan Medical Center, Daegu, Korea. ⁷Department of Cardiology, Pusan National University Hospital, Busan, Korea. ⁸Department of Cardiology, Seoul National University Hospital, Seoul, Korea. ⁹Department of Cardiology, Samsung Medical Center, Seoul, Korea. ¹⁰Department of Cardiology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea. ¹¹Department of Cardiology, Korean University Guro Hospital, Seoul, Korea.

Comparison for Use of Losartan and Candesartan on 3-year Clinical Outcomes after Acute Myocardial Infarction in Korean Population

[Speaker] Seung-Woon Rha,Korea
¹Seung-Woon Rha, ¹Byoung Geol Choi, ¹Se Yeon Choi, ¹Jae Kyeong Byun, ¹Jinah Cha, ¹Cheol Ung Choi, ²Myung Ho Jeong and Other Korea Acute Myocardial Infarction Registry (KAMIR)-National Institutes of Health (NIH) investigators
¹Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea, ²The Heart Center of Chonnam National University Hospital, Gwangju, Republic of Korea

Prognostic role of VEGF-A in patients with acute myocardial infarction with ST-segment elevation during the 6-month follow-up period

[Speaker] Inna KUTIA,Ukraine
Inna KUTIA, Julia Rodionova, Mykola Kopytsya, Yaroslava Hylyva       
Government Institution “L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine”